Innate immunity in Alzheimer's disease

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer's disease (AD) is a leading cause of dementia, classically characterized by amyloid-β plaques and neurofibrillary tangles.
• Emerging evidence highlights neuroinflammation and innate immune system activation as critical factors in AD pathogenesis.
• Chronic immune activation and impaired microglial clearance contribute to AD progression.

Purpose of the Study:

• To review recent advances in understanding the molecular mechanisms of neuroinflammation in Alzheimer's disease.
• To explore the role of the innate immune system in AD pathology.
• To identify novel therapeutic strategies targeting inflammatory pathways in AD.

Main Methods:

• Review of experimental, genetic, and epidemiological data.
• Analysis of molecular mechanisms underlying inflammatory responses in AD.
• Synthesis of current research on neuroinflammation and AD.

Main Results:

• Sustained amyloid-β aggregate formation triggers chronic immune activation.
• Dysfunctional microglial clearance mechanisms are implicated in AD.
• Neuroinflammation is a key disease-promoting factor in Alzheimer's disease.

Conclusions:

• Neuroinflammation is a central component of Alzheimer's disease pathology.
• Targeting innate immune system activation presents promising therapeutic avenues for AD.
• Further research into inflammatory pathways could lead to effective AD treatments.